Profylaktisk brug af prostaglandinsyntesehæmmere ved oplægning af spiral

Ugeskrift for Laeger

Volumn 160, Issue 48, 1998, Pages 6958-6961

  Jensen, Henrik Halvor ^a,b   Blaabjerg, Jan ^a   Lyndrup, Jens ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; IBUPROFEN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; PAIN; PAIN ASSESSMENT; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

BIOLOGY; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTIVE METHODS; DENMARK; DEVELOPED COUNTRIES; DISEASES; DOUBLE-BLIND STUDIES; ENDOCRINE SYSTEM; ENZYME INHIBITORS; ENZYMES AND ENZYME INHIBITORS; EUROPE; FAMILY PLANNING; INSERTION; IUD; IUD, COPPER RELEASING; NORTHERN EUROPE; PAIN; PHYSIOLOGY; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; RESEARCH METHODOLOGY; RESEARCH REPORT; SCANDINAVIA; SIGNS AND SYMPTOMS; STUDIES; TREATMENT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IBUPROFEN; INTRAUTERINE DEVICES; INTRAUTERINE DEVICES, COPPER; PAIN MEASUREMENT; PROSPECTIVE STUDIES;

EID: 2442650616     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bergsjø P, ed. Update on the intrauterine contraceptive device. Acta Obstet Gynecol Scand 1992; 71: 163-5.
2. Goldstuck ND, Matthews ML. A comparison of the actual and expected pain response following insertion of an intrauterine contraceptive device. Clin Reprod Fertil 1985; 3: 65-71.
3. Chi IC, Wilkens LR, Champion CB, Machemer RE, Rivera R. Insertional pain and other IUD insertion-related rare events for breastfeeding and non-breastfeeding women - a decade's experience in developing countries. Adv Contracept 1989, 5: 101-19.
4. Berger GS, Edelman DA, Regenie S Patients responses to IUD insertion. Int J Gynecol Obstet 1976; 14: 147.
5. Guillebaud J, Bounds W. Control of pain associated with intra-uterine device insertion using mefenamic acid Res Clin Forum 1983; 5: 69.
6. Goldstuck ND. Pain reduction during and after insertion of an intrauterine contraceptive device. Adv Contracept 1987; 3. 25-36.
7. Hillier K, Kasonde JM. Prostaglandin E and F content in human endometrium after insertion of intrauterine contraceptive devices. Lancet 1976, I: 15-6.
8. Chan WY, Dawood MY, Fuchs F. Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid Am J Obstet Gynecol 1979; 135: 102-8.
9. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. New York: Oxford University Press, 1987: 235-9.
10. Ylikorkala O, Kauppila A, Siljander M. Anti-prostaglandin therapy in prevention of side-effects of intrauterine contraceptive devices. Lancet 1978; II: 393-5.
11. Massey SE, Varady JC, Henzl MR. Pain relief with naproxen following insertion of an intrauterine device. J Reprod Med 1974; 13: 226-31.
12. Buttram V, Allen I, Henzl MR Naproxen sodium in uterine pain following intrauterine contraceptive device insertion. Am J Obstet Gynecol 1979, 134: 575-8.
13. Ylikorkala O, Viinikka L. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices. Br J Obstet Gynaecol 1983; 90: 78-83.